TANK-binding kinase 1 (TBK1): An emerging therapeutic target for drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TANK-binding kinase 1 (TBK1): An emerging therapeutic target for drug discovery

Published:2021-10 Issue:10 Volume:26 Page:2445-2455
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Xiang Shuang,Song Shukai,Tang Haotian,Smaill Jeff B.^ORCID,Wang Aiqun,Xie Hua,Lu Xiaoyun

Funder

National Key Research and Development Program of China

Health Research Council of New Zealand

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference85 articles.

1. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase;Pomerantz;EMBO J,1999

2. The pivotal role of TBK1 in inflammatory responses mediated by macrophages;Yu;Mediators Inflamm,2012

3. Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis;Hammaker;Rheumatology,2012

4. Are the IKKs and IKK-related kinases TBK1 and IKK-ɛ similarly activated?;Chau;Trends Biochem Sci,2008

5. Phosphorylation of the autophagy receptor optineurin restricts salmonella growth;Wild;Science,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiomyocyte-specific Tbk1 deletion aggravated chronic doxorubicin cardiotoxicity via inhibition of mitophagy;Free Radical Biology and Medicine;2024-09

2. Astragalin protects against lipopolysaccharide-triggered acute liver injury through suppression of necroptosis and inflammation and improvement of energy metabolism;Journal of Functional Foods;2024-07

3. The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-11

4. Role of TBK1 Inhibition in Targeted Therapy of Cancer;Mini-Reviews in Medicinal Chemistry;2024-06

5. cGAS–STING, an important signaling pathway in diseases and their therapy;MedComm;2024-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3